{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:02:54Z","timestamp":1793854974936,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","award":["P50 HD105354"],"award-info":[{"award-number":["P50 HD105354"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-1845298"],"award-info":[{"award-number":["DGE-1845298"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children&apos;s Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.eplepsyres.2022.106996","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T18:26:36Z","timestamp":1659896796000},"page":"106996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Quantitative electroencephalographic analysis as a potential biomarker of response to treatment with cannabidiol"],"prefix":"10.1016","volume":"185","author":[{"given":"Caren","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Zavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Mulcahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Sogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Gotoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Minnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2022.106996_bib1","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s13311-021-01132-4","article-title":"Electrophysiological biomarkers in genetic epilepsies","volume":"18","author":"Armstrong","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clinph.2019.06.234","article-title":"International federation of clinical neurophysiology (IFCN) \u2013 EEG research workgroup: Recommendations on frequency and topographic analysis of resting state EEG rhythms. Part 1: applications in clinical research studies","volume":"131","author":"Babiloni","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eplepsyres.2015.03.018","article-title":"Responders to vagus nerve stimulation (VNS) in refractory epilepsy have reduced interictal cortical synchronicity on scalp EEG","volume":"113","author":"Bodin","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-9-18","article-title":"EEG complexity as a biomarker for autism spectrum disorder risk","volume":"9","author":"Bosl","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib6","unstructured":"Calcagno, V., 2020. glmulti: Model Selection and Multimodel Inference Made Easy. R package version 1.0.8."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2006.05.003","article-title":"Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings","volume":"70","author":"Clemens","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2018.04.007","article-title":"1\/f neural noise and electrophysiological indices of contextual prediction in aging","volume":"1691","author":"Dave","year":"2018","journal-title":"Brain Res"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.05.013","article-title":"Open-label use of highly purified CBD (Epidiolex\u00ae) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes","volume":"86","author":"Devinsky","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ridd.2016.01.009","article-title":"Cognitive training modifies frequency EEG bands and neuropsychological measures in Rett syndrome","volume":"53","author":"Fabio","year":"2016","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib13","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/s41467-019-12202-9","article-title":"Longitudinal EEG power in the first postnatal year differentiates autism outcomes","volume":"10","author":"Gabard-Durnam","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib14","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib15","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0883073816669450","article-title":"Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases","volume":"32","author":"Gofshteyn","year":"2017","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib17","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1172\/JCI130419","article-title":"Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice","volume":"129","author":"Gu","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004691-199304000-00008","article-title":"Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients","volume":"10","author":"Herkes","year":"1993","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106988","article-title":"Cannabidiol in treatment of refractory epileptic spasms: an open-label study","volume":"106","author":"Herlopian","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2016.03.010","article-title":"Recent advances in resting-state electroencephalography biomarkers for autism spectrum disorder\u2014a review of methodological and clinical challenges","author":"Heunis","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-018-0557-x","article-title":"Quantitative pharmaco-electroencephalography in antiepileptic drug research","author":"H\u00f6ller","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.673135","article-title":"Results from an italian expanded access program on cannabidiol treatment in highly refractory dravet syndrome and lennox\u2013gastaut syndrome","author":"Iannone","year":"2021","journal-title":"Front. Neurol. 12."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.02.009","article-title":"Cannabidiol treatment for refractory seizures in sturge-weber syndrome","volume":"71","author":"Kaplan","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib25","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40263-021-00867-0","article-title":"Effect of cannabidiol on interictal epileptiform activity and sleep architecture in children with intractable epilepsy: a prospective open-label study","volume":"35","author":"Klotz","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib26","article-title":"caret: classification and regression training","author":"Kuhn","year":"2021","journal-title":"R. Package Version 6. 0-90"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yebeh.2012.02.024","article-title":"The effect of levetiracetam on focal nocturnal epileptiform activity during sleep \u2014 A placebo-controlled double-blind cross-over study","volume":"24","author":"Larsson","year":"2012","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.eplepsyres.2022.106996_bib28","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/epi.16546","article-title":"Cannabidiol efficacy and clobazam status: a systematic review and meta-analysis","volume":"61","author":"Lattanzi","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","article-title":"Highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond dravet syndrome and lennox\u2013gastaut syndrome","volume":"35","author":"Lattanzi","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib30","first-page":"55","article-title":"The case for medical marijuana in epilepsy","author":"Maa","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13229-020-00411-9","article-title":"Shifted phase of EEG cross-frequency coupling in individuals with Phelan-McDermid syndrome","volume":"12","author":"Mariscal","year":"2021","journal-title":"Mol. Autism"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib32","article-title":"Quantitative EEG analysis in angelman syndrome: candidate method for assessing therapeutics","author":"Martinez","year":"2020","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib33","first-page":"15","article-title":"Functional connectivity derived from electroencephalogram in pharmacoresistant epileptic encephalopathy using cannabidiol as adjunctive antiepileptic therapy","author":"Morales Chac\u00f3n","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cpdd.665","article-title":"A Phase 1, Open\u2010Label, Pharmacokinetic trial to investigate possible drug\u2010drug interactions between clobazam, stiripentol, or valproate and cannabidiol in healthy subjects","volume":"8","author":"Morrison","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107297","article-title":"Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy","volume":"112","author":"Nenert","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51385","article-title":"Delta power robustly predicts cognitive function in Angelman syndrome","author":"Ostrowski","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib37","first-page":"62","article-title":"The long-term efficacy of cannabidiol in the treatment of refractory epilepsy","author":"Patel","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib38","doi-asserted-by":"crossref","unstructured":"Perry, L., Szaflarski, J., Bebin, E., 2016. Investigating the effect of cannabidiol on the EEG. Neurol. Conf. 68th Am. Acad. Neurol. Annu. Meet. AAN 86.","DOI":"10.1212\/WNL.86.16_supplement.S14.007"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpn.2019.12.024","article-title":"Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: an open-label, prospective, interventional study","volume":"25","author":"Poisson","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ebcr.2018.07.004","article-title":"Successful use of pure cannabidiol for the treatment of super-refractory status epilepticus","volume":"10","author":"Rajaraman","year":"2018","journal-title":"Epilepsy Behav. Case Rep."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinph.2020.10.020","article-title":"Measuring the effects of first antiepileptic medication in temporal lobe epilepsy: predictive value of quantitative-EEG analysis","volume":"132","author":"Ricci","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib42","first-page":"11","article-title":"Electroencephalographic spectral power as a marker of cortical function and disease severity in girls with Rett syndrome","author":"Roche","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib43","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/epi.13815","article-title":"Quality of life in childhood epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol","volume":"58","author":"Rosenberg","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib44","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ana.26029","article-title":"Multisite study of evoked potentials in rett syndrome","volume":"89","author":"Saby","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/87565641.2011.614663","article-title":"The utility of EEG band power analysis in the study of infancy and early childhood","volume":"37","author":"Saby","year":"2012","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0013-4694(94)90090-6","article-title":"Intraindividual analysis of antiepileptic drug effects on EEG background rhythms","volume":"90","author":"Salinsky","year":"1994","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106263","article-title":"Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam","volume":"160","author":"Savage","year":"2020","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib48","first-page":"1","article-title":"Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis","volume":"9","author":"Sidorov","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib49","unstructured":"Soper, D.S., 2022. Fisher's Exact Test Calculator for a 3X3 Contingency Table [Software]. Available from \u3008https:\/\/www.danielsoper.com\/statcalc\u3009."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib50","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/epi.14477","article-title":"Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results","volume":"59","author":"Szaflarski","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s002490100143","article-title":"Pink-noise behaviour of biosystems","volume":"30","author":"Szendro","year":"2001","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/epi.14670","article-title":"Cannabidiol in patients with Lennox-Gastaut syndrome: interim analysis of an open-label extension study","volume":"60","author":"Thiele","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib55","doi-asserted-by":"crossref","first-page":"13257","DOI":"10.1523\/JNEUROSCI.2332-14.2015","article-title":"Age-related changes in 1\/f neural electrophysiological noise","volume":"35","author":"Voytek","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106996_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13229-021-00425-x","article-title":"Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability","volume":"12","author":"Wilkinson","year":"2021","journal-title":"Mol. Autism"},{"key":"10.1016\/j.eplepsyres.2022.106996_bib57","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/epi.16661","article-title":"Biomarkers of seizure response to vagus nerve stimulation: a scoping review","volume":"61","author":"Workewych","year":"2020","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:48:18Z","timestamp":1760276898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":57,"alternative-id":["S0920121122001474"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106996","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative electroencephalographic analysis as a potential biomarker of response to treatment with cannabidiol","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106996"}}